financetom
Business
financetom
/
Business
/
TransDigm Group Insider Sold Shares Worth $80,605,605, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TransDigm Group Insider Sold Shares Worth $80,605,605, According to a Recent SEC Filing
Mar 11, 2025 12:20 AM

03:14 AM EDT, 03/11/2025 (MT Newswires) -- Robert J Small, Director, on March 06, 2025, sold 60,000 shares in TransDigm Group ( TDG ) for $80,605,605. Following the Form 4 filing with the SEC, Small has control over a total of 587,186 common shares of the company, with 15,539 shares held directly and 571,647 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1260221/000091957425001878/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Senator Warren Says White House Should Stop Big Banks' 'Discriminatory' Practices
Update: Market Chatter: Senator Warren Says White House Should Stop Big Banks' 'Discriminatory' Practices
Feb 5, 2025
10:15 AM EST, 02/05/2025 (MT Newswires) -- (Updates with Citigroup ( C ) declining to comment in last paragraph.) US Senator Elizabeth Warren has told President Donald Trump that she believes the White House should move to stop alleged discriminatory practices by the country's largest banks, The Wall Street Journal reported Wednesday, quoting a letter from Warren's office. Warren said...
Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage
Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage
Feb 5, 2025
10:22 AM EST, 02/05/2025 (MT Newswires) -- Vaxcyte ( PCVX ) said Wednesday its ongoing phase 2 study assessing VAX-31 for the prevention of invasive pneumococcal disease in infants is advancing to its second and final stage. The company said participants who received VAX-31 in the first stage will continue the standard dosing regimen as part of the second stage....
Anglo Platinum CEO sees investor interest ahead of spinoff
Anglo Platinum CEO sees investor interest ahead of spinoff
Feb 5, 2025
* Amplats on track to spin off from parent Anglo this year * Miner will be only listed platinum stock on London bourse By Felix Njini and Clara Denina CAPE TOWN, Feb 5 (Reuters) - Anglo American Platinum is seeing a high level of investor interest in the business as it prepares to spin off as an independent entity from...
Illinois Tool Works Q4: Revenue Declines, EPS Tops Estimates, 2025 Outlook Signals Modest Growth & More
Illinois Tool Works Q4: Revenue Declines, EPS Tops Estimates, 2025 Outlook Signals Modest Growth & More
Feb 5, 2025
Illinois Tool Works Inc. ( ITW ) reported fourth-quarter revenue of $3.932 billion, a decline of 1.3% year over year and missing the consensus of $3.99 billion. Organic growth dropped 0.5% in revenue; excluding a 0.9% impact from Product Line Simplification, organic growth was positive at 0.4%. Revenue By Segments: Automotive OEM $785 million (-4% YoY), Food Equipment $672 million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved